Undernutrition and Treatment Success in Drug-Resistant Tuberculosis in Uganda.

MDR TB anaemia drug resistant malnutrition tuberculosis undernutrition

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2021
Historique:
received: 01 08 2021
accepted: 02 09 2021
entrez: 16 9 2021
pubmed: 17 9 2021
medline: 17 9 2021
Statut: epublish

Résumé

Undernutrition is associated with unfavourable treatment outcomes among people with drug-resistant tuberculosis (DRTB). Factors influencing the treatment outcomes among undernourished people with DRTB are not well characterised. The aim of this study was to determine factors associated with treatment success among undernourished people with DRTB in Uganda. We analysed data from a retrospective cohort of people with DRTB from 16 treatment sites in Uganda. We included participants with a pre-treatment body mass index (BMI) of <18.5 kilograms/meters Among 473 people with DRTB, 276 (58.4%) were undernourished (BMI < 18.5 Kg/m Most undernourished people with DRTB have severe undernutrition. Smoking and anaemia are modifiable factors which upon appropriate intervention could improve treatment success. The effect of urban residence on the TSR needs to be evaluated further.

Sections du résumé

BACKGROUND BACKGROUND
Undernutrition is associated with unfavourable treatment outcomes among people with drug-resistant tuberculosis (DRTB). Factors influencing the treatment outcomes among undernourished people with DRTB are not well characterised. The aim of this study was to determine factors associated with treatment success among undernourished people with DRTB in Uganda.
METHODS METHODS
We analysed data from a retrospective cohort of people with DRTB from 16 treatment sites in Uganda. We included participants with a pre-treatment body mass index (BMI) of <18.5 kilograms/meters
RESULTS RESULTS
Among 473 people with DRTB, 276 (58.4%) were undernourished (BMI < 18.5 Kg/m
CONCLUSION CONCLUSIONS
Most undernourished people with DRTB have severe undernutrition. Smoking and anaemia are modifiable factors which upon appropriate intervention could improve treatment success. The effect of urban residence on the TSR needs to be evaluated further.

Identifiants

pubmed: 34526787
doi: 10.2147/IDR.S332148
pii: 332148
pmc: PMC8437412
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3673-3681

Informations de copyright

© 2021 Baluku et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests in this work.

Références

Res Rep Trop Med. 2020 Jun 25;11:45-51
pubmed: 32612406
J Clin Tuberc Other Mycobact Dis. 2021 Jan 27;23:100221
pubmed: 33553682
Ann Glob Health. 2017 May - Aug;83(3-4):501-508
pubmed: 29221522
EClinicalMedicine. 2020 Feb 10;20:100268
pubmed: 32300732
PLoS One. 2014 Mar 18;9(3):e91229
pubmed: 24642636
BMC Infect Dis. 2020 Apr 28;20(1):315
pubmed: 32345228
Nutrients. 2020 Aug 21;12(9):
pubmed: 32825756
PLoS One. 2012;7(4):e35948
pubmed: 22545150
Int J Infect Dis. 2021 Apr;105:230-233
pubmed: 33610787
PLoS One. 2019 May 16;14(5):e0215968
pubmed: 31095582
Epidemiol Infect. 2020 Oct 15;148:e258
pubmed: 33054897
Lancet. 2015 May 2;385(9979):1799-1801
pubmed: 25814376
Front Immunol. 2020 Sep 24;11:588405
pubmed: 33072136
Lancet Infect Dis. 2019 Aug;19(8):903-912
pubmed: 31281059
Pan Afr Med J. 2021 Mar 17;38:279
pubmed: 34122706
Environ Health Prev Med. 2021 Jan 23;26(1):13
pubmed: 33485299
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1430-6
pubmed: 25390734
Clin Exp Immunol. 2020 Feb;199(2):230-243
pubmed: 31631328
Int J Tuberc Lung Dis. 2019 May 1;23(5):587-593
pubmed: 31097067
J Clin Tuberc Other Mycobact Dis. 2020 Dec 29;22:100211
pubmed: 33458257
Infect Chemother. 2016 Dec;48(4):317-323
pubmed: 27883374
Antibiotics (Basel). 2019 Jul 09;8(3):
pubmed: 31323935
BMC Pulm Med. 2019 Oct 21;19(1):182
pubmed: 31638950
Front Immunol. 2017 Oct 18;8:1316
pubmed: 29093710
Am J Epidemiol. 2012 Sep 1;176(5):409-22
pubmed: 22791739
Cochrane Database Syst Rev. 2016 Jun 29;(6):CD006086
pubmed: 27355911
Indian J Med Res. 2020 Jun;151(6):598-603
pubmed: 32719234
PLoS One. 2013 Nov 08;8(11):e80122
pubmed: 24260344
PLoS One. 2020 Dec 29;15(12):e0244451
pubmed: 33373997
Eur Respir J. 2009 May;33(5):1085-94
pubmed: 19164345
Tuberc Res Treat. 2019 Feb 12;2019:3569018
pubmed: 30891315
Tuberculosis (Edinb). 2020 Dec;125:101994
pubmed: 33049436
Chin Med J (Engl). 2015 Dec 5;128(23):3219-30
pubmed: 26612299
PLoS One. 2013 Dec 05;8(12):e82943
pubmed: 24349402
Lancet Infect Dis. 2021 Mar 23;:
pubmed: 33770535
Pulm Med. 2013;2013:828939
pubmed: 23476764
Clin Infect Dis. 2016 Feb 15;62(4):418-430
pubmed: 26508515
PLoS One. 2013 Oct 24;8(10):e77979
pubmed: 24205052
BMC Infect Dis. 2021 Jan 4;21(1):1
pubmed: 33390160
PLoS One. 2021 Feb 2;16(2):e0245458
pubmed: 33529195
PLoS One. 2018 Apr 20;13(4):e0195985
pubmed: 29677205
Respiration. 2013;86(6):472-8
pubmed: 23689646
Am J Trop Med Hyg. 2021 Mar 15;:
pubmed: 33724924
Clin Infect Dis. 2008 Aug 15;47(4):496-502
pubmed: 18611154
Bull World Health Organ. 1995;73(5):673-80
pubmed: 8846494
Thorax. 2015 Dec;70(12):1181-8
pubmed: 26506854

Auteurs

Joseph Baruch Baluku (JB)

Division of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.
Research and Innovation Department, Makerere University Lung Institute, Kampala, Uganda.

Sharon Namiiro (S)

Research and Innovation Department, Makerere University Lung Institute, Kampala, Uganda.

Martin Nabwana (M)

Quality Management Division, Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.

Winters Muttamba (W)

Research and Innovation Department, Makerere University Lung Institute, Kampala, Uganda.

Bruce Kirenga (B)

Research and Innovation Department, Makerere University Lung Institute, Kampala, Uganda.

Classifications MeSH